Septerna, Inc. (SEPN)
41.86
-6.70
(-13.80%)
USD |
NASDAQ |
Nov 12, 16:00
41.27
-0.59
(-1.41%)
After-Hours: 20:00
Septerna Profit Margin (Quarterly) : -140.8% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -140.8% |
| June 30, 2026 | -48.73% |
| March 31, 2026 | -32.56% |
| December 31, 2025 | -44.52% |
| September 30, 2025 | 38.02% |
| June 30, 2025 | -20.87K% |
| March 31, 2025 | -9.81K% |
| Date | Value |
|---|---|
| December 31, 2024 | -9.75K% |
| September 30, 2024 | -11.66K% |
| June 30, 2024 | -4.44K% |
| March 31, 2024 | -4.47K% |
| December 31, 2023 | |
| September 30, 2023 | -33.17K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -3.01K% |
| CNBX Pharmaceuticals, Inc. | -- |
| Arvinas, Inc. | -10.78K% |
| Fulcrum Therapeutics, Inc. | -- |
| Definium Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -15.02% |
| Return on Assets | -9.95% |
| Return on Invested Capital | -14.19% |
| Gross Profit Margin (Quarterly) | 97.91% |
| Operating Margin (Quarterly) | -144.2% |
| Return on Net Operating Assets | -135.7% |